Health Condition 1: G939- Disorder of brain, unspecified Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Propofol-Ketamine Group: Participants will receive 0.2 mL/kg of 0.5% propofol (mixture of 1% propofol and 0.9% saline) and 1 mg/kg of diluted ketamine in 0.9% saline (total 2 mL), follo
Sponsors
Shibani Padhy
Eligibility
Inclusion criteria
Inclusion criteria: ASA physical status I to II Elective MRI Under Deep Sedation
Exclusion criteria
Exclusion criteria: 1. History of thoracic surgery 2. Associated pulmonary pathology eg. atelectasis, pneumonia, pneumothorax, or pleural effusion based on preoperative chest roentgenogram or Ultrasound and CT chest when available 3.Current respiratory infection with fever greter than 38?C, purulent cough, yellowish nose discharge, or wheezing sound, 4. Airway abnormality 5. Allergy or contraindications for the study drugs 6. Duration of MRI more than 2hours 7. Patient refusal 8. Inability to obtain a pre sedation baseline USG scan
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of pulmonary atelectasis determined by lung ultrasonography. Atelectasis is defined as a juxtapleural consolidation score (C score) greater than 1 in more than one region, as determined by the lung ultrasound examinationTimepoint: From starting of anaesthesia to lung Ultrasound in the postsedation period. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Total lung score 2. Diaphragm excursion 3. Outcome:Respiratory complications 4. Outcome:Image quality 5. Adverse events during sedation and recovery 6. Recovery Profile(time to emergence and duration of PACU stay)Timepoint: 72hrs post MRI | — |
Countries
India
Contacts
Public ContactShibani Padhy
Nizams Institute of medical sciences
Outcome results
None listed